Abstract
Companion diagnostic tests are crucial in the development of precision medicine. These tests provide information that is essential for the safe and effective use of specific therapeutic products. Statistics plays a key role in the design and analysis of studies to demonstrate the safety and effectiveness of the companion diagnostics. This article can serve as an introduction to companion diagnostics for therapeutic statisticians and for diagnostic ones as well as a discussion of some of the statistical challenges. The topics include biomarker development, diagnostic performance, misclassification, prospective-retrospective validation, bridging studies, missing data, follow-on diagnostics and complex signatures.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
